Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?

Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks Investment Research • Dec 10, 2025

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?

Does Aurinia Pharmaceuticals (AUPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Dec 5, 2025

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?

San Diego-based Tang Capital Management increased its position in AUPH by 1.3 million shares in the third quarter. Following the transaction, Tang reported holding more than 11.3 million AUPH shares valued at $125.2 million.

The Motley Fool • Dec 2, 2025

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?

Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks Investment Research • Nov 24, 2025

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?

Aurinia Pharmaceuticals (AUPH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research • Nov 7, 2025

Aurinia Pharmaceuticals Inc. (AUPH) Q3 2025 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. ( AUPH ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Peter Greenleaf - President, CEO & Director Joseph Miller - Chief Financial Officer Greg Keenan - Chief Medical Officer Conference Call Participants Stacy Ku - TD Cowen, Research Division Olivia Brayer - Cantor Fitzgerald & Co., Research Division Maurice Raycroft - Jefferies LLC, Research Division Will Soghikian - Leerink Partners LLC, Research Division Yu He - H.C. Wainwright & Co, LLC, Research Division David Martin - Bloom Burton & Co., Research Division Douglas Miehm - RBC Capital Markets, Research Division Presentation Operator Good morning.

Seeking Alpha • Nov 4, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2025, and provided an update on recent business progress. Financial Results Total Revenue: For the three and nine months ended September 30, 2025, total revenue was $73.5 million and $205.9 million, up 8% and 17%, respectively, from $67.8 million and $175.3 million, respectively, for the same periods of 2024. Net Pro.

Business Wire • Nov 4, 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.1 per share a year ago.

Zacks Investment Research • Nov 4, 2025

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will report financial results for the three and nine months ended September 30, 2025, and provide an update on recent business progress on November 4, 2025. Aurinia's management team will host a webcast and conference call on November 4, 2025, at 8:30 a.m. ET. The link to the webcast is available here. To join the conference call, please dial 877-407-9170 / +1 201-493-6756. A.

Business Wire • Nov 3, 2025

Wall Street Breakfast Podcast: FDA Executive Controversy

Aurinia Pharmaceuticals (AUPH) files a federal lawsuit against FDA's George Tidmarsh for alleged false statements about its lupus nephritis drug. Baidu's (BIDU) Apollo Go robotaxi service matches Waymo's weekly ride volume, while Pony AI (PONY) prepares for a major Hong Kong IPO.

Seeking Alpha • Nov 3, 2025